PL414469A1 - Sposób wykrywania zwiększonego ryzyka zachorowania na raka nerki oraz zastosowania genotypowych wariantów genów GRHL1 i/lub GRHL2 i/lub GRHL3 - Google Patents

Sposób wykrywania zwiększonego ryzyka zachorowania na raka nerki oraz zastosowania genotypowych wariantów genów GRHL1 i/lub GRHL2 i/lub GRHL3

Info

Publication number
PL414469A1
PL414469A1 PL414469A PL41446915A PL414469A1 PL 414469 A1 PL414469 A1 PL 414469A1 PL 414469 A PL414469 A PL 414469A PL 41446915 A PL41446915 A PL 41446915A PL 414469 A1 PL414469 A1 PL 414469A1
Authority
PL
Poland
Prior art keywords
grhl3
grhl1
grhl2
genes
kidney cancer
Prior art date
Application number
PL414469A
Other languages
English (en)
Other versions
PL234915B1 (pl
Inventor
Magdalena Pawlak
Agnieszka Kikulska
Tomasz Wilanowski
Bartosz Wilczyński
Joanna Wesoły
Original Assignee
Instytut Biologii Doświadczalnej Im. M. Nenckiego Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biologii Doświadczalnej Im. M. Nenckiego Polskiej Akademii Nauk filed Critical Instytut Biologii Doświadczalnej Im. M. Nenckiego Polskiej Akademii Nauk
Priority to PL414469A priority Critical patent/PL234915B1/pl
Priority to PCT/IB2015/059225 priority patent/WO2017068402A1/en
Publication of PL414469A1 publication Critical patent/PL414469A1/pl
Publication of PL234915B1 publication Critical patent/PL234915B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Zgłoszenie dotyczy metod identyfikacji polimorfizmów pojedynczego nukleotydu (ang. single nucleotide polymorphism - SNP) w genach GRHL1 i/lub GRHL2 i/lub GRHL3 oraz wykorzystania tych polimorfizmów jako markerów do określenia zwiększonej podatności pacjentów na zachorowanie na raka nerki.
PL414469A 2015-10-23 2015-10-23 Sposób wykrywania zwiększonego ryzyka zachorowania na raka nerki oraz zastosowania genotypowych wariantów genów GRHL1 i/lub GRHL2 i/lub GRHL3 PL234915B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL414469A PL234915B1 (pl) 2015-10-23 2015-10-23 Sposób wykrywania zwiększonego ryzyka zachorowania na raka nerki oraz zastosowania genotypowych wariantów genów GRHL1 i/lub GRHL2 i/lub GRHL3
PCT/IB2015/059225 WO2017068402A1 (en) 2015-10-23 2015-11-30 A method for detecting an increased risk of kidney cancer and the use of genotype variants of genes grhl1 and / or grhl2 and / or grhl3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL414469A PL234915B1 (pl) 2015-10-23 2015-10-23 Sposób wykrywania zwiększonego ryzyka zachorowania na raka nerki oraz zastosowania genotypowych wariantów genów GRHL1 i/lub GRHL2 i/lub GRHL3

Publications (2)

Publication Number Publication Date
PL414469A1 true PL414469A1 (pl) 2017-04-24
PL234915B1 PL234915B1 (pl) 2020-05-18

Family

ID=55359545

Family Applications (1)

Application Number Title Priority Date Filing Date
PL414469A PL234915B1 (pl) 2015-10-23 2015-10-23 Sposób wykrywania zwiększonego ryzyka zachorowania na raka nerki oraz zastosowania genotypowych wariantów genów GRHL1 i/lub GRHL2 i/lub GRHL3

Country Status (2)

Country Link
PL (1) PL234915B1 (pl)
WO (1) WO2017068402A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005024603A2 (en) * 2003-09-10 2005-03-17 The Board Of Regents Of The University Of Texas System Methods for detecting, diagnosing and treating human renal cell carcinoma
WO2013029116A1 (en) 2011-08-31 2013-03-07 Monash University Method for predicting treatment responsiveness
AU2014367369B2 (en) * 2013-12-19 2020-03-26 Instytut Biologii Doswiadczalnej Im. M. Nenckiego Polskiej Akademii Nauk A method for detecting an increased risk of developing skin cancer and a use of a genotype variant of the GRHL3 gene

Also Published As

Publication number Publication date
WO2017068402A1 (en) 2017-04-27
PL234915B1 (pl) 2020-05-18

Similar Documents

Publication Publication Date Title
MX2022007933A (es) Compuestos de polimetino y su uso como etiquetas fluorescentes.
WO2015058008A3 (en) Enhanced nucleic acid identification and detection
IL246615B (en) Method for generating double stranded dna libraries and sequencing methods for the identification of methylated cytosines
EP3440226A4 (en) FOR THE DETECTION OF THE NEARLY RELATED ALL-MULTIPLEX NUCLEIC ACID TEST METHOD AND REAGENTS THEREFOR
MA40761A (fr) Utilisation de panels de gènes mutants du fgfr dans l'identification de patients atteints de cancer qui seront sensibles à un traitement avec un inhibiteur du fgfr
MX386750B (es) MARCADORES DE METILACIÓN Y DE miARN PARA LA DETECCIÓN DE CÁNCER.
EP3458966A4 (en) DEVICES AND METHODS FOR CARRYING OUT INTRA MODULE DATABUS INVERSION OPERATIONS
EA201400117A1 (ru) Способы и нуклеиновые кислоты для определения прогноза у больных раком
CL2014003526A1 (es) Métodos para tratar neoplasias resistentes al inhibidor tirosina quinasa en pacientes con polimorfismos genéticos o desregulaciones ahi1 o mutaciones que usan dianhidrogalactitol, diacetildianhidrogalactitol, dibromodulcitol o análogos o derivados de los mismos.
BR112015002626A2 (pt) métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa
MX2017011910A (es) Métodos, herramientas y sistemas para la evaluación, prevención, manejo y selección de tratamiento para diabetes tipo 2.
EP4246144A3 (en) Compositions and methods for screening mutations in thyroid cancer
SA518392005B1 (ar) تحديد خصائص التسلسل العميق للأورام
BR112015008621A2 (pt) Métodos e kit de diagnóstico e/ou prognóstico in vitro microconjunto de ácidos nucleicos.
FR3031641B1 (fr) Procede d'identification d'une entite
MX390053B (es) Metodos de evaluacion genomica en ganado.
TW201612518A (en) Methods of identifying patients suffering from liver cancer who will most likely benefit from a treatment with an antagonist anti-FGFR4 antibody
EP3294309A4 (en) NUCLEIC ACID MOLECULES WITH SPACERS AND METHOD FOR USE THEREOF
BR112017003559A2 (pt) métodos para a detecção rápida e sensível de mutações de locais-alvo
MX374415B (es) Composiciones y métodos para identificar un riesgo de cáncer en un sujeto.
FR3043811B1 (fr) Procede d'identification d'une entite
MX2022013471A (es) Metodo y composiciones de deteccion y cuantificacion de acido nucleico.
EP3258964A4 (en) IDENTIFICATION AND TREATMENT OF MALIGNEN TUMORS IN THE CNS
MA40636A (fr) Procédés pour détecter le cancer de la prostate
MX2016002529A (es) Marcadores de riesgo para cardiovasculopatias en pacientes con nefropatia cronica.